COMPOSITIONS AND METHODS FOR IDENTIFYING B CELL MALIGNANCIES RESPONSIVE TO B CELL DEPLETING THERAPY

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150252431A1
SERIAL NO

14638765

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides compositions and methods featuring the use of miR-629 for identifying subjects responsive to B-cell depleting therapies (e.g., treatment with an anti-CD19 antibody). In other embodiments, the invention features the use of miR-629 to identify subjects as having a B cell malignancy.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEDIMMUNE LLCONE MEDIMMUNE WAY GAITHERSBURG MD 20878

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BROHAWN, PHILIP Z GAITHERSBURG, US 5 2
KUZIORA, MICHAEL GAITHERSBURG, US 5 7
RANADE, KOUSTUBH GAITHERSBURG, US 33 95
STREICHER, KATIE GAITHERSBURG, US 19 21
YAO, YIHONG GAITHERSBURG, US 52 114

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation